BKSW — Baikang Biological group Cashflow Statement
0.000.00%
Last trade - 00:00Consumer DefensivesMicro Cap
Annual cashflow statement for Baikang Biological group, fiscal year end - April 30th, USD millions except per share, conversion factor applied.
2017 April 30th | 2018 April 30th | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG |
| Status: | Final | Final |
| Net Income/Starting Line | 7.38 | 14.9 |
| Depreciation | ||
| Deferred Taxes | ||
| Non-Cash Items | 0 | 0.015 |
| Unusual Items | ||
| Changes in Working Capital | -0.489 | 3.75 |
| Change in Accounts Receivable | ||
| Change in Inventories | ||
| Change in Prepaid Expenses | ||
| Change in Accounts Payable | ||
| Change in Accrued Expenses | ||
| Change in Taxes Payable | ||
| Cash from Operating Activities | 8.78 | 21.1 |
| Capital Expenditures | -0.818 | -3.64 |
| Purchase of Fixed Assets | ||
| Purchase / Acquisition of Intangibles | ||
| Cash from Investing Activities | -0.818 | -3.64 |
| Net Issuance / Retirement of Debt | ||
| Cash from Financing Activities | -7.52 | -17.2 |
| Foreign Exchange Effects | ||
| Beginning Cash Balance | ||
| Ending Cash Balance | ||
| Net Change in Cash | 0.425 | 0.293 |